- 1、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。。
- 2、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载。
- 3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
- 4、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
- 5、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们。
- 6、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
- 7、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
s4hara system for hivaids resource allocations4hara系统条件资源分配
Cost Effectiveness and Resource
Allocation BioMed Central
Research Open Access
S4HARA: System for HIV/AIDS resource allocation
1 1 2
Arielle Lasry , Michael W Carter and Gregory S Zaric*
Address: 1Department of Mechanical and Industrial Engineering, University of Toronto, Toronto, ON, M5S 3G8, Canada and 2Ivey School of
Business, University of Western Ontario, London, ON, N6A 3K7, Canada
Email: Arielle Lasry - alasry@; Michael W Carter - carter@mie.utoronto.ca; Gregory S Zaric* - gzaric@ivey.uwo.ca
* Corresponding author
Published: 26 March 2008 Received: 27 June 2007
Accepted: 26 March 2008
Cost Effectiveness and Resource Allocation 2008, 6:7 doi:10.1186/1478-7547-6-7
This article is available from: /content/6/1/7
© 2008 Lasry et al; licensee BioMed Central Ltd.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (/licenses/by/2.0),
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract
Background: HIV/AIDS resource allocation decisions are influenced by political, social, ethical and
other factors that are difficult to quantify. Consequently, quantitative models of HIV/AIDS resource
allocation have had limited impact on actual spending decisions. We propose a decision-support
System for HIV/AIDS Resource Allocation (S4HARA) that takes into consideration bot
您可能关注的文档
- risk of acute myocardial infarction with nonselective non-steroidal anti-inflammatory drugs a meta-analysis急性心肌梗塞的风险与非选择性非甾体抗炎药一个荟萃分析.pdf
- risk factors for the development of acute lung injury in patients with infectious pneumonia发展的危险因素患者急性肺损伤感染肺炎.pdf
- risk of contrast induced nephropathy in the critically ill a prospective, case matched study对比诱发肾病的风险病危前瞻性,案例匹配研究.pdf
- risk of bias tool in systematic reviewsmeta-analyses of acupuncture in chinese journals偏见的风险工具系统reviewsmeta-analyses针灸在中国期刊.pdf
- risk of end-stage renal disease associated with gout a nationwide population study终末期肾病的风险与痛风全国人口研究.pdf
- risk of advanced colorectal neoplasia according to age and gender先进的结直肠肿瘤的风险根据年龄和性别.pdf
- risk of cardio-respiratory abnormalities in preterm infants placed in car seats a cross-sectional study早产儿呼吸异常的风险放在汽车座椅一个横断面研究.pdf
- risk of future trauma based on alcohol screening scores a two-year prospective cohort study among us veterans未来基于酒精筛查创伤的风险分数两年美国退伍军人的前瞻性群组研究.pdf
- risk of hematological malignancies associated with magnetic fields exposure from power lines a case-control study in two municipalities of northern italy血液恶性肿瘤与磁场相关的风险敞口从电线意大利北部的病例对照研究在两个直辖市.pdf
- risk of bacterial contamination of bone harvesting devices used for autogenous bone graft in implant surgery细菌污染的风险骨收获设备用于自体移植骨植入手术.pdf
- safety and efficacy of methylene blue combined with artesunate or amodiaquine for uncomplicated falciparum malaria a randomized controlled trial from burkina faso安全性和有效性的亚甲蓝结合青蒿琥酯或阿莫地喹无并发症恶性疟疾来自布基纳法索的随机对照试验.pdf
- safety and efficacy of oral dmsa therapy for children with autism spectrum disorders part b - behavioral results口服dmsa疗法的安全性和有效性自闭症谱系障碍儿童b -部分行为的结果.pdf
- safety and immunogenicity of a malaria vaccine, plasmodium falciparum ama-1msp-1 chimeric protein formulated in montanide isa 720 in healthy adults一种疟疾疫苗的安全性和免疫原性,恶性疟原虫ama-1msp-1嵌合蛋白制定720年montanide isa在健康的成人.pdf
- saba is the h. pylori hemagglutinin and is polymorphic in binding to sialylated glycans沙巴是幽门螺旋杆菌血凝素和多态在绑定sialylated聚糖.pdf
- safety and clinical outcomes of rituximab therapy in patients with different autoimmune diseases experience from a national registry (graid)利妥昔单抗治疗的安全性和临床结果不同的自身免疫性疾病患者的经验从一个国家注册(妊娠).pdf
- safety and efficacy of topiramate in neonates with hypoxic ischemic encephalopathy treated with hypothermia (neonati)托吡酯的安全性和有效性在新生儿缺氧缺血性脑病治疗体温过低(neonati).pdf
- safety and immunogenicity of an ama-1 malaria vaccine in malian adults results of a phase 1 randomized controlled trialama-1疟疾疫苗的安全性和免疫原性马里成人阶段1随机对照试验的结果.pdf
- safety assessment of drotrecogin alfa (activated) in the treatment of adult patients with severe sepsis安全评估drotrecogin阿尔法(激活)治疗成人严重脓毒症患者.pdf
- safety and reactogenicity of canarypox alvac-hiv (vcp1521) and hiv-1 gp120 aidsvax be vaccination in an efficacy trial in thailand金丝雀的安全性和不良反应范畴alvac-hiv(vcp1521)和hiv - 1抗体来源于aidsvax疫苗在泰国的药效试验.pdf
- safety and immunogenicity study of multiclade hiv-1 adenoviral vector vaccine alone or as boost following a multiclade hiv-1 dna vaccine in africamulticlade hiv - 1 adenoviral向量疫苗的安全性和免疫原性研究单独使用或作为提高后multiclade hiv - 1在非洲的dna疫苗.pdf
文档评论(0)